CAMD Digital Biomarkers Conference

Use of Biosensors in Clinical Trials:

Barriers & Solutions to the Current Landscape

March 31 – April 1, 2016
Bethesda North Marriott Conference Center

Interest in identifying, evaluating and qualifying innovative technologies for use in drug development is growing. While regulatory guidance documents exist for pursuing novel Drug Development Tools (DDTs) and Medical Devices Development Tools (MDDTs) for Qualification, the use of Digital Biomarkers (i.e., measured biological events or patient function captured through a device or sensor technology) for use in clinical development remains ill-defined. This conference examines the current landscape of our use of Digital Biomarkers in clinical trials, the challenges faced, and the need for solutions to these challenges.

Agenda
Presentations: